About this podcast
Tune in to BioCentury’s in-depth conversations with global leaders who are advancing the future of medicine. Join our Senior Editors in face-to-face discussions with scientific KOLs, top executives, VCs, and key policymakers, dissecting the most urgent public health issues. The BioCentury Show is THE only place where BioCentury’s experts join top innovators and global influencers to show how science is being turned into medicine. Don't miss this event, every two weeks, now available as a video…
70 episodes · science
The BioCentury Show
About this podcast
Tune in to BioCentury’s in-depth conversations with global leaders who are advancing the future of medicine. Join our Senior Editors in face-to-face discussions with scientific KOLs, top executives, VCs, and key policymakers, dissecting the most urgent public health issues. The BioCentury Show is THE only place where BioCentury’s experts join top innovators and global influencers to show how science is being turned into medicine. Don't miss this event, every two weeks, now available as a video…
Recent episodes
- Ep. 117 - C-Path's Klaus Romero on moving genetic medicines beyond one patient21 Aug · 30 min
- Ep. 116 - Ovid's Jeremy Levin on biotech in the balance7 Aug · 33 min
- Ep. 115 - Initiate's Owens on what it takes to be AI-native23 Jul · 40 min
- Ep. 114 - Roivant’s Matt Gline on commercial launches and the future of the vant model10 Jul · 42 min
- Ep. 113 - Frank Jiang on Hengrui’s rise and China’s new era of biopharma dealmaking25 Jun · 35 min
- Ep. 112 - Chris Arendt on rebuilding Takeda for AI18 Jun · 40 min
- Ep. 111 - McGill's Angela Genge on why ALS drug development is turning a corner12 Jun · 37 min
- Ep. 110 - Richard Pops on Three Decades in Biotech: Drug pricing, FDA and China28 May · 38 min
- Ep. 109 - Mind the Gap: Karen Knudsen on Fixing Cancer Drug Development15 May · 36 min
- Ep. 108 - Rethinking Discovery: Chris Hollowood on Causal Biology and Syncona’s Strategy1 May · 33 min
podlinkr.com/en/the-biocentury-show
For a poster or slide.